v3.24.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Assets [Abstract]    
Cash and cash equivalents $ 286,132 $ 119,639
Cash collateral posted to counterparties 123,131 118,225
Mortgage-backed securities (including pledged of $5,788,148 and $5,880,747, respectively), at fair value 6,193,139 6,038,948
Due from counterparties 27,379 1,313
Derivative assets 8,461 54,361
Accrued interest receivable 28,323 28,727
Other assets, net 17,037 8,537
Total assets 6,683,602 6,369,750
Liabilities:    
Repurchase agreements 5,494,428 5,381,104
Due to counterparties 49,606 95
Derivative liabilities 2,032 0
Cash collateral posted by counterparties 19,382 46,001
Accrued interest payable 54,567 53,194
Accrued dividends payable 12,785 10,320
Other liabilities 5,539 8,301
 Total liabilities 5,638,339 5,499,015
Preferred Stock, Liquidation Preference, Value 111,500 111,500
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.00 per share; 50,000 shares authorized; 4,460 and 4,460 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 180,000,000 shares authorized; 74,707,776 and 57,038,247 shares issued and outstanding, respectively 747 570
Additional paid-in capital 1,620,355 1,404,431
Accumulated other comprehensive loss (177,556) (158,502)
Accumulated deficit (506,126) (483,607)
 Total shareholders’ equity 1,045,263 870,735
Total liabilities and shareholders’ equity $ 6,683,602 $ 6,369,750

Source

10-Q PDF XBRL Zip